Is FISH floating or still swimming in the lung cancer ocean?

Ann Oncol. 2011 Mar;22(3):493-499. doi: 10.1093/annonc/mdq752. Epub 2011 Feb 3.

Authors

F Cappuzzo¹, D R Camidge², M Varella-Garcia²

Affiliations

¹ Department of Medical Oncology, Istituto Toscano Tumori-Ospedale Civile di Livorno, Livorno, Italy. Electronic address: f.cappuzzo@googlemail.com.
² Departments of Medicine/Medical Oncology; Pathology, University of Colorado Denver, Aurora, USA.

PMID: 21292645
DOI: 10.1093/annonc/mdq752

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antineoplastic Agents / therapeutic use*
Biomarkers, Tumor / genetics
Biomarkers, Tumor / metabolism
ErbB Receptors / genetics*
ErbB Receptors / metabolism
Erlotinib Hydrochloride
Gefitinib
Humans
In Situ Hybridization, Fluorescence*
Lung Neoplasms / diagnosis*
Lung Neoplasms / drug therapy
Lung Neoplasms / genetics
Meta-Analysis as Topic
Molecular Diagnostic Techniques
Mutation
Quinazolines / therapeutic use
Small Cell Lung Carcinoma / diagnosis*
Small Cell Lung Carcinoma / drug therapy
Small Cell Lung Carcinoma / metabolism
Treatment Outcome

Substances

Antineoplastic Agents
Biomarkers, Tumor
Quinazolines
Erlotinib Hydrochloride
ErbB Receptors
Gefitinib